Guidelines for Examination in the European Patent Office
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
En Munich, 26.09.2019 SUBJECT: President's Activities Report SUBMITTED BY
CA/88/19 Orig.: en Munich, 26.09.2019 SUBJECT: President's activities report SUBMITTED BY: President of the European Patent Office ADDRESSEES: Administrative Council (for information) CA/88/19 e 2019-7203 - I - TABLE OF CONTENTS Subject Page I. INTRODUCTION 1 II. GOAL 1: BUILD AN ENGAGED, KNOWLEDGEABLE AND COLLABORATIVE ORGANISATION 1 III. GOAL 2: SIMPLIFY AND MODERNISE EPO IT SYSTEMS 6 IV. GOAL 3: DELIVER HIGH-QUALITY PRODUCTS AND SERVICES EFFICIENTLY 10 V. GOAL 4: BUILD A EUROPEAN PATENT SYSTEM AND NETWORK WITH A GLOBAL IMPACT 21 VI. GOAL 5: SECURE LONG-TERM SUSTAINABILITY 37 VII. RECOMMENDATION FOR PUBLICATION 42 CA/88/19 e 2019-7203 I. INTRODUCTION Transparency of the Office's activities is ensured through regular reporting to the Council. The present report outlines the major developments and most relevant endeavours characterising 2019 so far. In June the Council unanimously approved the Strategic Plan 2023 (SP2023) that encompasses the five strategic goals the Office will pursue to evolve into a sustainable office that delivers excellence. Until now the reporting had a configuration linked to the various business areas and to the relevant departmental subdivisions, focusing more upon the operations of the Office. This report seeks to gradually move towards a report that more closely reflects SP2023, following its structure and describing the achievements in the various goals and key initiatives. This report therefore needs to be understood as a transitional one that will improve alongside the implementation of the programmes and projects of the SP. The Office also intends to propose a better aligned and more comprehensive reporting process. -
How to Get a European Patent
European Patent Guide How to get a European patent 19th edition Updated to 1 April 2019 Contents Chapter 1 – Foreword .................................................................................. 7 Chapter 2 – General ..................................................................................... 9 2.1 Introduction ................................................................................................................... 9 2.2 Nature and purpose of the European Patent Convention ....................................... 10 2.3 Relationship to other international conventions ..................................................... 11 2.4 Choosing a route: national, European or international........................................... 12 Legal factors ...................................................................................................... 12 Economic factors ............................................................................................... 13 2.5 Extending/validating European patents to/in non-contracting states ................... 14 Chapter 3 – Patentability ........................................................................... 16 3.1 Introduction ................................................................................................................. 16 3.2 Invention ...................................................................................................................... 16 3.3 Novelty ........................................................................................................................ -
The European Patent Convention, 3 Md
Maryland Journal of International Law Volume 3 | Issue 2 Article 10 The urE opean Patent Convention Follow this and additional works at: http://digitalcommons.law.umaryland.edu/mjil Part of the International Law Commons, and the International Trade Commons Recommended Citation The European Patent Convention, 3 Md. J. Int'l L. 408 (1978). Available at: http://digitalcommons.law.umaryland.edu/mjil/vol3/iss2/10 This Notes & Comments is brought to you for free and open access by DigitalCommons@UM Carey Law. It has been accepted for inclusion in Maryland Journal of International Law by an authorized administrator of DigitalCommons@UM Carey Law. For more information, please contact [email protected]. THE EUROPEAN PATENT CONVENTION The European Patent Convention' (EPC) is an attempt to simplify European patent law. The Convention provides a procedure for securing a single, European patent,2 which has the effect of a national patent in the signatory nations designated in the application. Through this alternative to national procedures, widespread patent coverage should be easier to obtain. Require- patent, however, are rigorous and its ments for a European 3 attraction is primarily the consolidation of the grant procedures. The EPC establishes several organs to handle the various aspects of the patent application procedure. The European Patent Office (EPO), located in Munich, is the international equivalent of a national patent office. Its administrative divisions are the General Search Division, the Examining Division, and the Opposition Division. The Receiving Section is at The Hague. The first procedural step is the filing of an application at either a national patent office or directly with the EPO.4 The application may be in any of the three official languages (English, French, or German) and the applicant's choice becomes the language of the proceedings.5 The Receiving Section subjects the application to both a preliminary6 and a supplementary formal examination to determine whether it is in proper form and all fees are paid. -
Trademark Examination Guidelines
STATE INTELLECTUAL PROPERTY OFFICE OF THE REPUBLIC OF CROATIA TRADEMARK EXAMINATION GUIDELINES December 2014 SIPO Trademark Examination Guidelines Contents Contents CHAPTER I INTRODUCTION AND LEGAL FRAMEWORK 1 1.1 Introduction 1 1.2 Legal Framework 1 CHAPTER II RECEIPT OF APPLICATIONS AND FORMALITIES EXAMINATION 3 2.1 Receipt of Application 3 2.2 Accordance of a Filing Date of an Application 3 2.2.1 Requirements 3 2.2.2 Remedy of Deficiencies (Article 22 of the Act) 4 2.3 Additional Requirements 4 2.3.1 Applicant 5 2.3.1.1 Applicant’s Name and Address (Article 32 of the Regulations) 6 2.3.2 Representative 6 2.3.2.1 Representative’s Name and Address (Article 32 paragraphs 2 and 4 of the Regulations) 7 2.3.2.2 Power of Attorney 7 2.3.3 Indication and List of the Goods and Services (Article 2, paragraphs 1 and 2, and Article 10, paragraph 1 of the Regulations) 7 2.3.4 Priority Right 7 2.3.4.1 Union Priority Right (Article 18 of the Act) 7 2.3.4.2 Exposition Priority Right (Article 19 of the Act) 8 2.3.5 Indication and Representation of a Sign 9 2.3.5.1 Verbal Sign (Article 3 of the Regulations) 9 2.3.5.2 Figurative Sign (Article 4 of the Regulations) 9 2.3.5.3 Three-dimensional Sign . (Article 5 of the Regulations). 9 2.3.5.4 Signs Consisting of one Colour or of a Combination of Colours (Article 6 of the Regulations) 10 2.3.5.5 Other Types of Signs (Article 7 of the Regulations) 10 2.3.5.6 Other Requirements Concerning the Representation of a Sign (Article 8 of the Regulations) 10 2.3.5.7 Attachments to the Application (Article 9 of the -
PCT Applicant's Guide – National Phase
DE PCT Applicant’s Guide – National Phase – National Chapter – DE Page 1 GERMAN PATENT AND TRADE MARK OFFICE (DEUTSCHES PATENT- UND MARKENAMT) AS DESIGNATED (OR ELECTED) OFFICE CONTENTS THE ENTRY INTO THE NATIONAL PHASE—SUMMARY THE PROCEDURE IN THE NATIONAL PHASE ANNEXES Fees ............................................................... Annex DE.I National processing request form (patents) .................................. Annex DE.II National processing request form (utility models) .............................. Annex DE.III Declaration concerning the inventor ....................................... Annex DE.IV List of abbreviations: Office: German Patent and Trade Mark Office PatG: Patent Act [Patentgesetz] GebrMG: Utility Model Act [Gebrauchsmustergesetz] IntPatÜbkG: Act on International Patent Conventions [Gesetz über internationale Patentübereinkommen] PatKostG: Patent Costs Act [Patentkostengesetz] PatKostZV: Ordinance on Payment of Patent Costs of the German Patent and Trade Mark Office and the Federal Patent Court [Patentkostenzahlungsverordnung] DPMAV: Ordinance concerning the German Patent and Trade Mark Office [Verordnung über das Deutsche Patent- und Markenamt] (25 March 2021) DE PCT Applicant’s Guide – National Phase – National Chapter – DE Page 3 SUMMARY Designated SUMMARY (or elected) Office DE GERMAN PATENT AND DE TRADE MARK OFFICE Summary of requirements for entry into the national phase Time limits applicable for entry into the Under PCT Article 22(1): 30 months from the priority date national phase: Under PCT Article -
President's Activities Report SUBMITTED BY
CA/88/18 Orig.: en Munich, 21.09.2018 SUBJECT: President's activities report SUBMITTED BY: President of the European Patent Office ADDRESSEES: Administrative Council (for information) CA/88/18 e 2018-4859 - I - TABLE OF CONTENTS Subject Page I. INTRODUCTION 1 II. PERFORMANCE OF THE PATENT GRANTING PROCESS 2 A. WORKLOAD AND PRODUCTION 2 B. QUALITY 7 a) Quality action plans 8 b) Quality Management System 8 c) Asian documentation 9 d) Cooperative Patent Classification (CPC) 10 e) Harmonisation efforts in relation to ICT 12 f) Harmonisation in the HBC sector: biotechnology and pharmaceutical patents 14 g) Procedures and Guidelines 14 C. RELATIONS WITH USERS 15 a) User support 15 b) User feedback 16 c) Communication with applicants 17 III. SOCIAL DIALOGUE 18 IV. IT AND AUTOMATION PROJECTS 19 A. ITR – DELIVERIES FOR THE PGP AND KMS 19 a) Delivering the digital transformation agenda 20 b) Improvements to existing tools 21 c) Other tool adaptations 21 B. DELIVERIES FOR OTHER AREAS 22 a) Corporate area 22 b) Infrastructure/data centres 23 C. LAUNCH OF AN IT AUDIT 23 V. BUILDINGS 23 A. NEW MAIN THE HAGUE 23 B. OTHER BUILDING PROJECTS 25 a) Status review of EPO premises – overview 25 CA/88/18 e 2018-4859 - II - VI. EPN 33 A. CO-OPERATION WITH MEMBER STATES 33 B. EUROPEAN PATENT ACADEMY 34 a) Institutional Strengthening 34 b) Judicial Training 34 c) Professional Representatives 34 d) Academia 35 e) E-learning 35 C. CO-OPERATION WITH THE EUIPO 35 D. REPRESENTATION BEFORE THE EPO 36 E. EUROPEAN PATENT REGISTER 36 F. -
Patent Cooperation Treaty for Private Applicants | 19
Patent Cooperation Treaty (PCT) for Private Applicants 1 June 2021 Intellectual Property Office is an operating name of the Patent Office 1 | Intellectual Property Office Patent Cooperation Treaty (PCT) GB Receiving Office Notes for Private Applicants This note is intended to serve as a basic introduction to filing International patent applications under the Patent Cooperation Treaty (PCT) with the GB Receiving Office at the Intellectual Property Office. Whilst we have made every effort to cover important aspects this note is not comprehensive and you are advised to read the various PCT Guides issued by WIPO (World Intellectual Property Organisation) and to seek advice when in doubt. THE PCT SYSTEM IS COMPLEX. YOU ARE STRONGLY ADVISED TO SEEK THE HELP OF A CHARTERED PATENT AGENT. Deadlines A chart showing the timelines for action on your application is attached at ANNEX B. Reminders will not be issued at any stage during the processing of your application and failure to meet deadlines may mean you incurring surcharges or even losing your application. 2 | Intellectual Property Office Introduction The Patent Cooperation Treaty (PCT) system allows applicants seeking patent protection, in a number of countries, to file a single international application in English with the Intellectual Property Office. The International Unit at the Intellectual Property Office acts as the GB Receiving Office under the PCT. A PCT application has the same effect as a regular filing in each of the national or regional Offices of the PCT Contracting States that you select or designate when you complete the PCT Request form PCT/RO/101. Your PCT application is processed through 2 basic stages, the International Phase and the National (for example: seeking a national UK patent) or Regional Phase (for example: seeking a regional European patent). -
Taking Care of Article 6Bisness: How Belmora LLC V. Bayer Consumer Care AG Made the Well-Known Mark Doctrine Inevitable in the U.S
Washington Journal of Law, Technology & Arts Volume 12 | Issue 4 Article 4 4-1-2017 Taking Care of Article 6bisness: How Belmora LLC v. Bayer Consumer Care AG Made the Well-Known Mark Doctrine Inevitable in the U.S. Gwen Wei Follow this and additional works at: https://digitalcommons.law.uw.edu/wjlta Part of the Intellectual Property Law Commons Recommended Citation Gwen Wei, Taking Care of Article 6bisness: How Belmora LLC v. Bayer Consumer Care AG Made the Well-Known Mark Doctrine Inevitable in the U.S., 12 Wash. J. L. Tech. & Arts 501 (2017). Available at: https://digitalcommons.law.uw.edu/wjlta/vol12/iss4/4 This Article is brought to you for free and open access by the Law Reviews and Journals at UW Law Digital Commons. It has been accepted for inclusion in Washington Journal of Law, Technology & Arts by an authorized editor of UW Law Digital Commons. For more information, please contact [email protected]. Wei: Taking Care of Article 6<i>bis</i>ness: How <i>Belmora LLC v. Bay WASHINGTON JOURNAL OF LAW, TECHNOLOGY & ARTS VOLUME 12, ISSUE 4 SPRING 2017 TAKING CARE OF ARTICLE 6BISNESS: HOW BELMORA LLC V. BAYER CONSUMER CARE AG MADE THE WELL-KNOWN MARK DOCTRINE INEVITABLE IN THE U.S. Gwen Wei* © Gwen Wei CITE AS: 12 WASH. J.L. TECH. & ARTS 501 (2017) http://digital.law.washington.edu/dspace-law/handle/1773.1/1793 ABSTRACT In Belmora LLC v. Bayer Consumer Care AG, the Fourth Circuit held that a foreign company with no U.S. federal trademark registration for "FLANAX" could nevertheless demand cancellation of its competitor's U.S. -
World Intellectual Property Organization Geneva
E WIPO SCIT/ATR/PI/1999/EP WORLD INTELLECTUAL PROPERTY ORGANIZATION GENEVA STANDING COMMITTEE ON INFORMATION TECHNOLOGIES ANNUAL TECHNICAL REPORT 1999 ON PATENT INFORMATION ACTIVITIES* submitted by the EUROPEAN PATENT OFFICE An annual series of reports on the patent information activities of members of the Standing Committee on Information Technologies * – The term “patent” covers utility models and SPCs. – Information related to design patent activities reported by industrial property offices issuing design patents is included in the series of documents SCIT/ATR/ID. European Patent Office Technical Report on Patent Information Activities in 1999 European Patent Office 29 May 2000 Technical Report on Patent Information Activities in 1999 Page II Table of Contents I. EVOLUTION OF PATENT ACTIVITIES ........................................................................... 1 II. MATTERS CONCERNING GENERATION, REPRODUCTION, DISTRIBUTION AND USE OF PRIMARY AND SECONDARY SOURCES OF PATENT INFORMATION....... 2 1. Printing and Publication of Patent Documents........................................................... 2 1.1 Patent Applications ............................................................................................ 2 1.2 Granted Patents................................................................................................. 3 2. Main Types of Announcements in the Field of Patent Information ............................ 4 3. Publication Media....................................................................................................... -
The European Patent Office
INTEllECTUAl PROPERTY 286 CHIMIA 2000, 54, No.5 Chimia 54 (2000) 286-287 © Neue Schweizerische Chemische Gesellschatl ISSN 0009-4293 Safeguarding Europe-Wide Patent Protection: the European Patent Office Ulrich Schatz* Abstract: The European patent system, created in 1977, provides for the co-existence of a national and a centralised procedure for the grant of patents. Central grant authority for European patents is the European Patent Office in Munich, which carries out its task on the basis of the provisions laid down in the European Patent Convention. The establishment of a Europe-wide patent system has led to a significant increase in the demand for patent rights in Europe. Inthe framework of their co-operation, the member states of the European Patent Organisation have also created a unique patent information network for accessing the information contained in patent documents. In view of its impending eastward expansion, the European Patent Organisa- tion is set to undertake a revision of the European patent system to ensure its flexibility in the future. Keywords: esp@cenet . Europe· Innovation· Internet· Patent information' Patents The conclusion of the European Patent borders proves that this Organisation has grounds for revocation by the EPO in an Convention on 5 October 1973 was an changed the landscape of industrial prop- opposition procedure and those by na- important milestone on the road to a uni- erty protection in Europe. The worldwide tional courts in revocation or infringe- fied patent in Europe. In 1997 the Europe- development in the field of patents has, ment procedures. Furthermore, the Con- an Patent Office celebrated its 20th anni- moreover, been significantly influenced vention provides for professional repre- versary, The founding of the European by the European Patent Convention enter- sentation before the EPO, creates the Patent Organisation in 1977 and the open- ing into force. -
Electronic Copy Available At
Policy Levers Tailoring Patent Law to Biotechnology. Comparing US and European Approaches Geertrui Van Overwalle Professor of IP Law at the University of Leuven (Belgium) Professor of Patent Law and New Technologies at the University of Tilburg (the Netherlands) Working paper – April 2010 To be published in University of California Irvine Law Review (forthcoming) Table of content 1. Introduction 1.1. “The patent crisis” 1.2. Objective and scope of the present study 1.2.1. European patent law 1.2.2. Policy levers 1.2.3. Biotechnology 2. Biotech-specific policy levers in Europe 2.1. Patent acquisition 2.1.1. Patentable subject matter – inventions and discoveries 2.1.2. Patentable subject matter – morality 2.1.3. Patentable subject matter – medical methods 2.1.4. Novelty – first and second medical use 2.1.5. Novelty – selection invention 2.1.6. Novelty – testing exemption 2.1.7. Inventive step – expectation of success 2.1.8. Inventive step – secondary indicia – commercial success 2.1.9. Industrial applicability 2.1.10. Skilled person 2.1.11. Enabling disclosure 2.2. Patent scope 2.2.1. Scope of product claims – absolute vs. limited scope 2.2.2. Clarity of claims 2.2.3. Breadth of claims 2.3. Patent rights and limitations 2.3.1. Research exemption 2.3.2. Compulsory licensing 2.3.3. Patent term 3. Conclusions 3.1. European policy levers in biotechnology 3.1.1. Policy levers 3.1.2. Macro versus micro policy levers 3.1.3. Statutory versus jurisprudential policy levers 3.1.4. Pre-grant versus post-grant policy levers 3.1.5. -
“The Origin of Specis” (Patent Specifications) BASIC FACTS (A.K.A
The Origin of Specis (or, nearly everything you wanted to know about patents, but couldn’t be bothered asking) 22.Sep.2021 © Tony McStea 1992-2021 22.Sep.2021 About the Author… (with apologies to Gilbert and Sullivan) When I was a lad, I served a term As patent tech. assistant in a big paint firm I wrote applications and I argued and tried Patent offices to show that grant was justified And this sort of thing so suited me That now I’m patent attorney in industry. Acknowledgement My grateful thanks to all of you out there who helped me with this revised version by offering comments, corrections, criticisms, suggestions and advice, some of which I ignored, which is why the booklet still exists. The responsibility for any errors (not to mention the mediocre drawings and terrible jokes (or is it mediocre jokes and terrible drawings?)) is entirely mine. The responsibility for any views or opinions expressed herein is also entirely mine. N.B. Most costs mentioned herein were correct (more or less) at June, 2015, but, because of the tendency of official fees to fluctuation (and exchange rates to go up and down like yo-yos), and the consequent work of constantly adjusting them, they have been left as they are and are there to be general guides only. 22.Sep.2021 Note: changes to US Law On 16 March 2013 (thus missing by one day the Blessing of St. Patrick on the entire enterprise), the Leahy-Smith “America invents” Act (AIA), the most significant change to US patent law in half a century, came fully into effect.